Nuvo Pharmaceuticals Inc MRVFF

RE:RE:Reality Check

[lscfa]

Vimovo sales in the US were 15% of total sales for this latest quarter and the co. will not lose all of that any time soon to generics. The stock price has crashed 40%. Disconnect.  

Cubalibra wrote: Surely this has to be a good buy here doesn’t it? Oversold?

Was the news really that bad? How much will that news affect future sales?

Volume also seems low.

consultant99 wrote: I only venture back periodically after essentually selling almost all of my shares within the last two years. We fought unsuccssfully against the spin-off of Crescita when the share price was at $6.65

Since then the two enterprises have lost 64% of their value - $4.25/share!! BB has been intimately involved with Nuvo over the years and provided a positive opinion used by management to help sell the spin-off so keep that in mind when looking at their forecasted share price.

Jesse has taken a huge risk in acquiring the assets and I sincerely hope he is successful in turning Nuvo around - I know some long-suffering shareholders who deserve a break.

I still keep in touch with fellow investors that sold NRI and have moved on to a company called Theralase TLT. They successfully completed a phase 1 trial on bladder cancer and are now starting their phase 2 at Princess Margaret Hospital in Toronto. I have been in this company for a number of years and find it a compelling story. I have stopped recommending stocks on bulleton boards so do your own due diligence on this one.

There is a chance the stock can rise substantially from here if management can pull this off - worth hanging around for a quarter or two to see how they make out if you already own shares.